SPARQ
Live / Applied — Extension of time to oppose received (as of 06 Nov 2025)
What this means for you
Not registered yet, but its 08 Dec 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98890822
- Mark type
- Stylized text
- Filed
- 08 Dec 2024
- Published for opposition
- 07 Oct 2025
- Attorney of record
- Randolph E. Digges, III
Goods and services
- Class 001 — Chemicals: Nonmedical reagents, enzymes and buffer solutions for scientific and/or medical research use, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; mineral coated particles, artificial and synthetic resins in the form magnetic or superparamagnetic particles, for use in isolating nucleic acids or proteins; kits comprising chemicals for sample preparation, modification and manipulation of cells; kits comprising chemicals for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material; kits comprising in particular chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
- Class 005 — Pharmaceuticals: Preparations for medical and veterinary purposes for sample preparation, and for marking, separating, isolating, purifying and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification and enrichment; preparations for medical and veterinary purposes, namely mineral coated particles, artificial and synthetic resins in the form magnetic or superparamagnetic particles, for use in isolating nucleic acids or proteins; chemical, biochemical and biotechnological preparations, in particular reagents, enzymes and buffer solutions for sample preparation and for marking, separating, isolating, purifying and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification and enrichment; kits containing preparations for medical and veterinary purposes, in particular for sample preparation and for marking, separating, isolating, purifying and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification and enrichment
Owner
- Quantabio, LLC, Beverly, MA, US
- Quantabio, LLC, Beverly, MA, US
Prosecution history
- 31 Mar 2026 — POST PUBLICATION AMENDMENT - ENTERED
- 31 Mar 2026 — ASSIGNED TO PETITION STAFF
- 02 Feb 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 06 Nov 2025 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 19 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 19 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Jun 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Jun 2025 — NON-FINAL ACTION E-MAILED
- 09 Jun 2025 — NON-FINAL ACTION WRITTEN
- 27 May 2025 — ASSIGNED TO EXAMINER